Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 61-70 of 76

Page
per page
  1. PF-3644022
    B5549 PF-3644022
    Target: MK2
    Summary: Potent and Selective MK2 inhibitor
      <14.98 mg/mL
  2. VX-702
    A8687 VX-702
    Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
      insoluble in H2O; ≥20.2 mg/mL
  3. PD318088
    A5707 PD318088
    Target: MEK
    Summary: Allosteric MEK1/2 inhibitor, non-ATP competitive
      ≥28.05 mg/mL
  4. VX-745
    A8686 VX-745
    Target: p38
    Summary: P38α inhibitor,highly potent and selective
      ≥21.8 mg/mL
  5. Salirasib
    A3787 Salirasib
     2 Citation
    Summary: Inhibitor of active Ras protein
  6. VX-11e
    A3931 VX-11e
     5 Citation
    Target: ERK
    Summary: ERK inhibitor
      ≥25 mg/mL
  7. CEP-32496 hydrochloride
    A3297 CEP-32496 hydrochloride
    Summary: B-Raf/C-Raf inhibitor,highly potent
      Soluble in DMSO
  8. RO5126766(CH5126766)
    B5820 RO5126766(CH5126766)
    Summary: Raf/MEK dual inhibitor
      insoluble in H2O; insoluble in EtOH; ≥35.7 mg/mL
  9. Cobimetinib
    A3321 Cobimetinib
     3 Citation
    Summary: Selective MEK inhibitor
      ≥26.55 mg/mL
  10. Losmapimod
    B4620 Losmapimod
     1 Citation
    Summary: p38 MAPK inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL

Items 61-70 of 76

Page
per page